» Articles » PMID: 23664135

Cell Type-specific Function of TAK1 in Innate Immune Signaling

Overview
Journal Trends Immunol
Date 2013 May 14
PMID 23664135
Citations 182
Authors
Affiliations
Soon will be listed here.
Abstract

Transforming growth factor β-activated kinase 1 (TAK1 or MAP3K7) is a key signaling component of nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways. Activation of TAK1 is tightly regulated through its binding partners and protein modifications. Although TAK1 functions as an essential and positive regulator of innate immune signaling and apoptosis in mouse embryonic fibroblasts (MEFs), T cells, and other cells, it negatively regulates cell development and activation of proinflammatory signaling pathways in neutrophils. However, the molecular mechanisms responsible for the opposite roles of TAK1 in different cell types remain to be addressed. In this article, we discuss the latest progresses in our understanding of TAK1 regulation, function, and mechanisms in a cell-type specific manner.

Citing Articles

Resiquimod induces a mixed Th1 and Th2 response via STAT1 and STAT3 signalling in chickens.

Kappala D, Ramakrishnan S, Nikunjkumar Prakashbhai P, Kaliappan A, Thomas P, Linde J Biochem Biophys Rep. 2025; 41:101941.

PMID: 39990625 PMC: 11847045. DOI: 10.1016/j.bbrep.2025.101941.


Neutrophil diversity and function in health and disease.

Zhang F, Xia Y, Su J, Quan F, Zhou H, Li Q Signal Transduct Target Ther. 2024; 9(1):343.

PMID: 39638788 PMC: 11627463. DOI: 10.1038/s41392-024-02049-y.


Ubiquitination and Metabolic Disease.

Ma M, Cao R, Tian Y, Fu X Adv Exp Med Biol. 2024; 1466:47-79.

PMID: 39546135 DOI: 10.1007/978-981-97-7288-9_4.


Bibliometric and visualized analysis on global trends and hotspots of TAK1 in regulated cell death: 1999 to 2024.

Huang K, He Y, Wan H, Ban X, Chen X, Hu X Front Immunol. 2024; 15:1437570.

PMID: 39474417 PMC: 11518718. DOI: 10.3389/fimmu.2024.1437570.


Cardiomyocyte-specific knockout of ADAM17 alleviates doxorubicin-induced cardiomyopathy via inhibiting TNFα-TRAF3-TAK1-MAPK axis.

Xie L, Xue F, Cheng C, Sui W, Zhang J, Meng L Signal Transduct Target Ther. 2024; 9(1):273.

PMID: 39406701 PMC: 11480360. DOI: 10.1038/s41392-024-01977-z.